Senseonics Holdings (SENS) Receives Daily News Sentiment Rating of 0.14

News stories about Senseonics Holdings (NASDAQ:SENS) have been trending somewhat positive this week, Accern Sentiment reports. Accern identifies negative and positive media coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Senseonics Holdings earned a coverage optimism score of 0.14 on Accern’s scale. Accern also assigned headlines about the company an impact score of 46.9429719457748 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

Several equities research analysts recently commented on the stock. Zacks Investment Research raised shares of Senseonics Holdings from a “sell” rating to a “hold” rating in a research note on Tuesday, August 15th. Canaccord Genuity reissued a “buy” rating on shares of Senseonics Holdings in a research note on Thursday, September 28th.

Shares of Senseonics Holdings (SENS) remained flat at $$2.65 during midday trading on Monday. The company had a trading volume of 152,008 shares, compared to its average volume of 606,882. Senseonics Holdings has a 1 year low of $1.26 and a 1 year high of $3.67.

Senseonics Holdings (NASDAQ:SENS) last issued its earnings results on Tuesday, October 31st. The company reported ($0.13) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.13). The firm had revenue of $2.10 million during the quarter, compared to the consensus estimate of $1.51 million. The company’s revenue was up 425.0% compared to the same quarter last year.

In other news, COO Mukul Jain sold 11,885 shares of the company’s stock in a transaction that occurred on Monday, October 2nd. The shares were sold at an average price of $3.25, for a total value of $38,626.25. The sale was disclosed in a filing with the SEC, which is accessible through this link.

TRADEMARK VIOLATION WARNING: This article was originally published by Chaffey Breeze and is the property of of Chaffey Breeze. If you are viewing this article on another publication, it was illegally copied and reposted in violation of United States and international copyright & trademark laws. The original version of this article can be read at

Senseonics Holdings Company Profile

Senseonics Holdings, Inc is a medical technology company. The Company focuses on the design, development and commercialization of glucose monitoring systems. The Company operates through glucose monitoring systems segment. It offers a continuous glucose monitoring (CGM) system, Eversense, which is designed an implantable CGM system designed to continually measure glucose levels in people with diabetes.

Insider Buying and Selling by Quarter for Senseonics Holdings (NASDAQ:SENS)

Receive News & Ratings for Senseonics Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics Holdings Inc and related companies with's FREE daily email newsletter.

Latest News

Leave a Reply